Issues include: Advertisement Patton doesnt mince words when it comes to this question: In my opinion, no, she states
However, the average age of WHI enrollees was 63, many were more than 10 years past menopause, and a substantial proportion had pre-existing cardiovascular risk factors
In December 2022, as demand for all GLP-1 drugs skyrocketed with the news that they could be safe and effective for obesity and weight management, FDA included tirzepatide on its shortage list, which opened the floodgates for compounded copies
One participant stated: "While on Mounjaro, I couldn't smoke, but after stopping it for about a month, I went back to smoking." (Male, 8 months on GLP-1 therapy) "During the period of use, the need for nicotine noticeably decreased, but after the treatment period ended, the desire to smoke gradually increased." (Male, 6 months on GLP-1 therapy) In contrast, a subset of participants reported no observable perceived impact of GLP-1 on their smoking behavior
Understanding when injections are clinically appropriate helps patients make informed decisions about their care
